Fisher Asset Management, LLC

Source: SEC Form 13F · as of Mar 2026

Fisher Asset Management, LLC holds 78 biotech & pharma companies tracked by BioSniper, totaling $17.01B in value as of Mar 2026 (SEC Form 13F).

Companies held

78

Total value held

$17.01B

CompanySharesValue
LLYELI LILLY & Co4,838,986$4.45B
MRKMerck & Co., Inc.26,436,284$3.18B
JNJJOHNSON & JOHNSON9,263,611$2.26B
AZNASTRAZENECA PLC10,845,708$2.14B
ABBVAbbVie Inc.9,092,054$1.98B
UNHUnitedHealth Group Incorporated Common Stock (DE)5,237,701$1.42B
AMGNAMGEN INC1,577,866$555.2M
ABTABBOTT LABORATORIES752,105$77.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.1,113,568$69.8M
MEDPMedpace Holdings Inc.135,712$65.2M
BIIBBIOGEN INC.312,618$57.3M
CYTKCYTOKINETICS INC768,264$50.6M
RCUSArcus Biosciences, Inc.2,190,404$47.3M
DNLIDenali Therapeutics Inc.2,436,895$46.8M
VRDNViridian Therapeutics, Inc.\DE1,768,295$34.6M
CLDXCelldex Therapeutics, Inc.1,013,648$32.2M
CGONCG Oncology, Inc.465,033$31.5M
IDYAIDEAYA Biosciences, Inc.882,699$29.4M
HALOHALOZYME THERAPEUTICS, INC.444,689$28.7M
CRNXCrinetics Pharmaceuticals, Inc.762,702$27.7M
BBIOBridgeBio Pharma, Inc.351,628$26.1M
BCRXBIOCRYST PHARMACEUTICALS INC2,733,253$26.0M
LGNDLigand Pharmaceuticals Incorporated127,994$25.6M
SRRKScholar Rock Holding Corp458,017$22.5M
RVMDREVOLUTION MEDICINES, INC.215,947$21.0M
KNSAKiniksa Pharmaceuticals International, plc428,972$20.7M
UTHRUNITED THERAPEUTICS Corp34,404$20.4M
PTGXProtagonist Therapeutics, Inc173,971$18.3M
ACADACADIA PHARMACEUTICALS INC732,872$16.3M
NBIXNEUROCRINE BIOSCIENCES INC122,226$16.1M
PBHPrestige Consumer Healthcare Inc.251,165$14.9M
VRTXVERTEX PHARMACEUTICALS INC / MA31,158$13.9M
ALKSAlkermes plc.390,479$13.8M
BMYBRISTOL MYERS SQUIBB CO203,654$12.4M
IONSIONIS PHARMACEUTICALS INC141,544$10.6M
INCYIncyte Corp.112,746$10.6M
NUVLNuvalent, Inc.97,518$10.0M
MIRMMirum Pharmaceuticals, Inc.93,109$8.6M
GMOptec International, Inc.107,820$8.0M
KRYSKrystal Biotech, Inc.27,784$7.2M
CMPXCompass Therapeutics, Inc.1,348,259$7.1M
COGTCogent Biosciences, Inc.167,412$6.4M
NRIXNurix Therapeutics, Inc.384,831$6.0M
VCELVericel Corp185,337$6.0M
DYNDyne Therapeutics, Inc.323,051$5.9M
KURAKura Oncology, Inc.675,305$5.5M
MYGNMYRIAD GENETICS INC1,190,896$5.4M
GLUEMonte Rosa Therapeutics, Inc.314,862$5.2M
RDYDR REDDYS LABORATORIES LTD364,745$5.1M
WSTWest Pharmaceutical Services Inc.18,638$4.7M
OLMAOlema Pharmaceuticals, Inc.299,756$4.5M
REGNREGENERON PHARMACEUTICALS, INC.5,059$3.9M
TNGXTango Therapeutics, Inc.162,399$3.4M
ANABANAPTYSBIO, INC56,596$3.1M
PTCTPTC THERAPEUTICS, INC.44,558$3.0M
PMPhilip Morris International Inc16,829$2.8M
ZYMEZymeworks Inc.101,439$2.5M
CPRXCATALYST PHARMACEUTICALS, INC.82,169$2.0M
BMRNBIOMARIN PHARMACEUTICAL INC35,480$2.0M
ALNYALNYLAM PHARMACEUTICALS, INC.6,045$2.0M
GILDGILEAD SCIENCES, INC.11,150$1.6M
TYRATyra Biosciences, Inc.28,800$1.1M
DNTHDianthus Therapeutics, Inc. /DE/12,620$1.1M
TVTXTravere Therapeutics, Inc.33,996$1.0M
MDXGMiMedx Group Inc246,569$974K
DAWNDay One Biopharmaceuticals, Inc.43,698$937K
CORCencora Inc.2,937$923K
STROSUTRO BIOPHARMA, INC.35,295$879K
IQVIQVIA Holdings Inc.4,743$809K
MCKMcKesson Corporation903$782K
SLDBSolid Biosciences Inc.103,481$745K
AURAAura Biosciences, Inc.83,508$559K
ELVElevance Health Inc.1,846$541K
CAHCardinal Health Inc.2,289$484K
IDXXIDEXX LABORATORIES INC /DE599$337K
ZTSZoetis Inc.2,344$277K
GEHCGE HealthCare Technologies Inc.3,216$229K
IGCIGC Pharma, Inc.43,400$11K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Fisher Asset Management, LLC — Biotech 13F Holdings & Portfolio | BioSniper